Three Execs Flee Major Pharma Company The Day Before Earning Report

Business | Robert Donachie
A box of Pfizer drug Viagra and a bottle of Allergan product Botox are seen in a combination of file photos. REUTERS/Mark Blinch/Shannon Stapleton/Files

‘These executives were integral players in Valeant’

Crooked Capitals -- From Washington To Albany

Opinion | Claudia Tenney

The hardworking American taxpayer needs a friend in Washington and in Albany and a break from corruption and cronyism.

Rumble On The Right -- It's Not What You Think

Opinion | Alison Acosta Fraser

The right should remember — pro-business policies are not necessarily pro-market

Republicans And Democrats Prepare To Revive Bank Of Corporate Welfare

Opinion | David Williams

It’s all but inevitable now that the corrupt Ex-Im Bank will be resurrected from the dead.

Illinois: Sweet Land of Stadium Subsidies

US | Peter Fricke

‘Corporate welfare at its worst’

Utah: Your Business Model's Not Welcome Here

Business | Peter Fricke

Regulators target start-up

Writing, And Benefiting, From Tax Laws

Business | Peter Fricke

‘The top ranks of the U.S. tax administration have swapped staff with industry for decades’

Government Turns Corporate Settlements Into Unaccountable Slush Fund

Business | Peter Fricke

‘Regulation by prosecution’

An Epic conflict of interest

Feature:Opinion | Pejman Yousefzadeh

How political favoritism is interfering with best practices in the health care industry.

Romney's cronyism problem is emblematic of contemporary politics

Feature:Opinion | Benjamin Domenech

In order to win support for Romneycare, the then-governor agreed to special subsidies for two large hospital systems.